What is Catequentinib hydrochloride used for?

Catequentinib hydrochloride is being studied for the treatment of neoplasms, which are tumors or cancers.

Is Catequentinib hydrochloride approved for use?

No, Catequentinib hydrochloride is currently in Phase 3 clinical trials and is not yet an approved medication.

What kind of drug is Catequentinib hydrochloride?

It is classified as a small molecule drug candidate.

What stage of testing is Catequentinib hydrochloride in?

It is currently in Phase 3 of clinical development.

Are there known side effects for Catequentinib hydrochloride?

There is no specific side effect information provided in the current data for Catequentinib hydrochloride.

Does Catequentinib hydrochloride have a black box warning?

No, there are currently no black box warnings listed for Catequentinib hydrochloride.

Anlotinib dihydrochloride | CAS 1360460-82-7 | UUAKQNIPIXQZFN

Loading compound...

Small molecule drug candidate

Catequentinib hydrochloride is a small molecule drug currently being studied in clinical trials (Phase 3) for the treatment of neoplasms (tumors/cancer).

How it worksThe specific biological mechanism for how this drug works is not yet detailed in the provided data.

Used for

Neoplasms (tumors or cancer)

Conditions

Neoplasms

Class

Small moleculeSmall molecule drug candidate

How to take

This drug is currently in clinical development and is not yet approved for general use.

Talk to your doctor

Questions to ask

·Is Catequentinib hydrochloride part of any clinical trials I can join?
·How does Catequentinib hydrochloride work for neoplasms?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.

How to take

Talk to your doctor

Frequently asked questions (6)